-
2
-
-
0042205092
-
Evidence of underdiagnosis of myasthenia gravis in older people
-
V incent A C lover L B uckley C et al. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003 74 1105 8.
-
(2003)
J Neurol Neurosurg Psychiatry
, vol.74
, pp. 1105-8
-
-
Vincent, A.1
Clover, L.2
Buckley, C.3
-
4
-
-
0031785532
-
Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis
-
V incent A W illcox N H ill M C urnow J M ac L ennan C B eeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 1998 164 157 68.
-
(1998)
Immunol Rev
, vol.164
, pp. 157-68
-
-
Vincent, A.1
Willcox, N.2
Hill, M.3
Curnow, J.4
MacLennan, C.5
Beeson, D.6
-
5
-
-
0036779688
-
Unravelling the pathogenesis of myasthenia gravis
-
Review
-
V incent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002 2 797 804. Review.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 797-804
-
-
Vincent, A.1
-
6
-
-
0031889914
-
End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis
-
R uff RL L ennon VA. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ann Neurol 1998 43 370 9.
-
(1998)
Ann Neurol
, vol.43
, pp. 370-9
-
-
Ruff, R.L.1
Lennon, V.A.2
-
7
-
-
0029006803
-
Acetylcholine release in myasthenia gravis: Regulation at single end-plate level
-
P lomp JJ V an K empen GT D e B aets MB et al. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Ann Neurol 1995 37 627 36.
-
(1995)
Ann Neurol
, vol.37
, pp. 627-36
-
-
Plomp, J.J.1
Van Kempen, G.T.2
De Baets, M.B.3
-
8
-
-
0032128319
-
Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss
-
G uyon T W akkach A P oea S M ouly V K lingel -S chmitt I L evasseur P et al. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. J Clin Invest 1998 102 249 63.
-
(1998)
J Clin Invest
, vol.102
, pp. 249-63
-
-
Guyon, T.1
Wakkach, A.2
Poea, S.3
Mouly, V.4
Klingel-Schmitt, I.5
Levasseur, P.6
-
9
-
-
26044471121
-
Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis
-
L osen M S tassen MH M artinez -M artinez P M achiels BM D uimel H F rederik P et al. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Brain 2005 128 2327 37.
-
(2005)
Brain
, vol.128
, pp. 2327-37
-
-
Losen, M.1
Stassen, M.H.2
Martinez-Martinez, P.3
MacHiels, B.M.4
Duimel, H.5
Frederik, P.6
-
10
-
-
0032924923
-
Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice
-
J acobson L P olizzi A M orriss -K ay G V incent A. Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice. J Clin Invest 1999 103 1031 8.
-
(1999)
J Clin Invest
, vol.103
, pp. 1031-8
-
-
Jacobson, L.1
Polizzi, A.2
Morriss-Kay, G.3
Vincent, A.4
-
11
-
-
0036135312
-
The agrin/muscle-specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junction
-
L iyanage Y H och W B eeson D V incent A. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 2002 25 4 16.
-
(2002)
Muscle Nerve
, vol.25
, pp. 4-16
-
-
Liyanage, Y.1
Hoch, W.2
Beeson, D.3
Vincent, A.4
-
12
-
-
0035105784
-
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
-
H och W M c C onville J H elms S et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001 7 365 8.
-
(2001)
Nat Med
, vol.7
, pp. 365-8
-
-
Hoch, W.1
McConville, J.2
Helms, S.3
-
13
-
-
0036718618
-
Anti-p110 autoantibodies identify a subtype of ''seronegative'' myasthenia gravis with prominent oculobulbar involvement
-
S cuderi F M arino M C olonna L et al. Anti-p110 autoantibodies identify a subtype of ''seronegative'' myasthenia gravis with prominent oculobulbar involvement. Lab Invest 2002 82 1139 46.
-
(2002)
Lab Invest
, vol.82
, pp. 1139-46
-
-
Scuderi, F.1
Marino, M.2
Colonna, L.3
-
14
-
-
33645511990
-
Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis
-
F arrugia ME K ennett RP N ewsom -D avis J H ilton -J ones D V incent A. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis. Muscle Nerve 2005.
-
(2005)
Muscle Nerve
-
-
Farrugia, M.E.1
Kennett, R.P.2
Newsom-Davis, J.3
Hilton-Jones, D.4
Vincent, A.5
-
15
-
-
26944499793
-
Neuromuscular junction autoimmune disease: Muscle specific kinase antibodies and treatments for myasthenia gravis
-
V incent A L eite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 2005 18 519 25.
-
(2005)
Curr Opin Neurol
, vol.18
, pp. 519-25
-
-
Vincent, A.1
Leite, M.I.2
-
17
-
-
13144277543
-
Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis
-
S hiraishi H M otomura M Y oshimura T F ukudome T F ukuda T N akao Y T sujihata M V incent A E guchi K. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005 57 289 93.
-
(2005)
Ann Neurol
, vol.57
, pp. 289-93
-
-
Shiraishi, H.1
Motomura, M.2
Yoshimura, T.3
Fukudome, T.4
Fukuda, T.5
Nakao, Y.6
Tsujihata, M.7
Vincent, A.8
Eguchi, K.9
-
18
-
-
28444450838
-
MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo
-
B enveniste O J acobson L F arrugia ME C lover L V incent A. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J Neuroimmunol 2005 170 41 8.
-
(2005)
J Neuroimmunol
, vol.170
, pp. 41-8
-
-
Benveniste, O.1
Jacobson, L.2
Farrugia, M.E.3
Clover, L.4
Vincent, A.5
-
19
-
-
17044374662
-
Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation
-
S preadbury I K ishore U B eeson D V incent A. Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation. J Neuroimmunol 2005 162 149 56.
-
(2005)
J Neuroimmunol
, vol.162
, pp. 149-56
-
-
Spreadbury, I.1
Kishore, U.2
Beeson, D.3
Vincent, A.4
-
20
-
-
0024418229
-
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder
-
V incent A L ang B N ewsom -D avis J. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989 12 496 502.
-
(1989)
Trends Neurosci
, vol.12
, pp. 496-502
-
-
Vincent, A.1
Lang, B.2
Newsom-Davis, J.3
-
21
-
-
0031879169
-
Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels
-
P into A M oss F L ang B B oot J B rust P W illiams M et al. Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels. Ann N Y Acad Sci 1998 841 687 90.
-
(1998)
Ann N Y Acad Sci
, vol.841
, pp. 687-90
-
-
Pinto, A.1
Moss, F.2
Lang, B.3
Boot, J.4
Brust, P.5
Williams, M.6
-
22
-
-
0036687356
-
Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions
-
G iovannini F S her E W ebster R B oot J L ang B. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine- treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions. Br J Pharmacol 2002 136 1135 45.
-
(2002)
Br J Pharmacol
, vol.136
, pp. 1135-45
-
-
Giovannini, F.1
Sher, E.2
Webster, R.3
Boot, J.4
Lang, B.5
-
23
-
-
0030755538
-
Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse
-
W aterman SA L ang B N ewsom -D avis J. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 1997 42 147 56.
-
(1997)
Ann Neurol
, vol.42
, pp. 147-56
-
-
Waterman, S.A.1
Lang, B.2
Newsom-Davis, J.3
-
27
-
-
10744229052
-
Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis
-
V incent A B uckley C S chott JM B aker I D ewar BK D etert N et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004 127 701 12.
-
(2004)
Brain
, vol.127
, pp. 701-12
-
-
Vincent, A.1
Buckley, C.2
Schott, J.M.3
Baker, I.4
Dewar, B.K.5
Detert, N.6
|